Lawrence Steinman
Academic Appointments
- Professor, Neurology & Neurological Sciences
- Member, Bio-X
- Professor, Pediatrics
Key Documents
Contact Information
-
Clinical Offices
Pediatric Neurology 730 Welch Rd Palo Alto, CA 94304 Tel Work (650) 723-0993 Fax (650) 724-5344Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-6401Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Neurology
- Neurology, Pediatric
- Multiple Sclerosis, Myasthenia Gravis, Immune Disorders
Administrative Appointments
- Chairman, Interdepartmental Program in Immunology, Interdepartmental Program in Immunology, Stanford University (2002 - 2011)
Honors and Awards
- Charcot Award for Lifetime Achievement in MS Research, Internation Federation of MS Societies (2011)
- Member, Institute of Medicine, National Academy of Sciences (October, 2009-)
- John M. Dystel Prize, American Academy of Neurology and National MS Society (2004)
- Friedrich Sasse Prize, Free Univ.of Berlin (1994)
- Sen. Jacob Javits Award, US Congress (1988-2002)
Professional Education
| Residency: | Stanford University School of Medicine CA (1980) |
| Residency: | Stanford University School of Medicine CA (1974) |
| Fellowship: | National Institutes of Health MD (1977) |
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (1984) |
| Fellowship: | Weizmann Institute Of Science, Israel (1977) |
| Internship: | Stanford University School of Medicine CA (1974) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Our laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
Publications
- A Tip leads cytotoxic T cells to the crime scene in neuroinflammation. Nat Immunol. 2013; (3): 196-7
- A writing-intensive course improves biology undergraduates' perception and confidence of their abilities to read scientific literature and communicate science. Adv Physiol Educ. 2013; (1): 70-9
- Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation. Sci Transl Med. 2013; (179): 179ra42
- Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat Cell Biol. 2013
- Inflammatory cytokines at the summits of pathological signal cascades in brain diseases. Sci Signal. 2013; (258): pe3
- Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011. Mult Scler. 2013; (1): 5-14
Help